KIP Infrastructure
2.27.3 -

This page is part of the KIP Infrastructure (v2.27.3: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

ValueSet: Immunoterapi

Official URL: https://kip.rkkp.dk/fhir/ValueSet/Immunoterapi Version: 2.27.3
Active as of 2022-07-18 Computable Name: Immunoterapi

Immunoterapi

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

This value set includes codes based on the following rules:

 

Expansion

This value set contains 9 concepts

SystemCodeDisplay (en)DefinitionJSONXML
https://kip.rkkp.dk/fhir/CodeSystem/GenericValues  noneIngen immunoterapiNone - used to choose none of the available values
https://kip.rkkp.dk/fhir/CodeSystem/ATC  L01FA01RituximabL01FA01 - rituximab
https://kip.rkkp.dk/fhir/CodeSystem/ATC  L01FA03ObinutuzumabL01FA03 - obinutuzumab
https://kip.rkkp.dk/fhir/CodeSystem/ATC  L01FA02OfatumumabL01FA02 - ofatumumab
https://kip.rkkp.dk/fhir/CodeSystem/ATC  L04AAMabCampathL04AA - Selective immunosuppressants
https://kip.rkkp.dk/fhir/CodeSystem/ATC  L01FX05Brentuximab vedotin (Adcetris)L01FX05 - brentuximab vedotin
https://kip.rkkp.dk/fhir/CodeSystem/ATC  L01FX14Polatuzumab incl evt. RituximabL01FX14 - polatuzumab vedotin
https://kip.rkkp.dk/fhir/CodeSystem/ATC  L01FFPD(L)1 hæmmereL01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors
https://kip.rkkp.dk/fhir/CodeSystem/TreatmentUnspecified  glofitamabGlofitamabel Epcoritamab Incl evt. RituximabGlofitamab

Description of the above table(s).